结石对充血性心力衰竭风险的影响
Marc Ganz1, Daniel Miller2, Jude Appiah1
1Department of Urology, State University of New York Downstate Health Sciences University, Brooklyn, USA.
Cureus
|July 12, 2024
概括
患有结石的病史与患上充血性心力衰竭 (CHF) 的风险显著增加有关. 这一发现强调了在心血管健康评估中考虑结石疾病的重要性.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是一个主要的全球健康问题,患病率和死亡率很高.
- 充血性心力衰竭 (CHF) 是HF的一个关键子集,影响全球数百万人.
- 新兴研究表明,结石和心血管疾病之间存在潜在联系.
研究的目的:
- 调查结石病史与充血性心力衰竭 (CHF) 风险之间的直接关系.
- 确定结石作为潜在的独立风险因子,为CHF.
主要方法:
- 在国家健康和营养检查调查 (NHANES) (2017年3月至2020年3月) 中,对8521名参与者的数据进行了后勤回归分析.
- 该分析对人口统计学变量进行了调整,包括年龄,性别,种族和教育程度.
- 评估了结石和CHF发病率之间的关联.
主要成果:
- 患有结石病史的个体患上心脏不全症的发病率较高 (7%),而没有 (3%).
- 结石被确定为CHF的独立风险因素,其几率比 (OR) 为1.857 (p < 0.01).
- 年龄,性别,种族和教育等人口因素也对心血管疾病风险产生了重大影响.
结论:
- 患有结石的病史与患心脏不全症的风险增加有关.
- 对于有结石病史的患者,建议加强心血管监测.
- 进一步研究结石与心血管健康之间的联系机制是有必要的.
相关概念视频
01:22Heart Failure Drugs: Diuretics
362
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
362
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
419
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
419
01:11Renal Failure: Dose Adjustments
79
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
79
01:45Kidney Structure
69.4K
The kidneys are two large bean-shaped organs located in the upper abdomen. They filter the blood several times a day to remove toxins and rebalance water and electrolytes of the circulatory system via the renal veins. The kidneys receive blood directly from the heart via the renal arteries. These arteries enter the kidney at the hilum, the concave surface of the bean, where they branch and divide into smaller vessels and capillaries.
69.4K
01:17Factors Affecting Renal Clearance: Renal Impairment
74
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
74
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K